Regulation of the Interleukin-6 gene expression during monocytic differentiation of HL-60 cells by chromatin remodeling and methylation

Immunobiology

Volumn 219, Issue 8, 2014, Pages 619-626

  Poplutz, Magdalena K ^a   Wessels, Inga ^a   Rink, Lothar ^a   Uciechowski, Peter ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Chromatin remodeling; Hyperacetylation; Interleukin (IL) 6; Methylation; Monopoiesis; Myeloid differentiation

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; TRICHOSTATIN A; 5 AZA 2' DEOXYCYTIDINE; AUTACOID; AZACITIDINE; DNA METHYLTRANSFERASE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; LIPOPOLYSACCHARIDE;

AMINO ACID SEQUENCE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; DEMETHYLATION; DNA METHYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; HISTONE METHYLATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN SECRETION; STEM CELL; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HL 60 CELL LINE; IMMUNOLOGY; METABOLISM;

AZACITIDINE; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; DNA MODIFICATION METHYLASES; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE INHIBITORS; HL-60 CELLS; HUMANS; HYDROXAMIC ACIDS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MONOCYTES; PROMOTER REGIONS, GENETIC;

EID: 84902085032     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.03.016     Document Type: Article

References (29)

1. Armenante F., Merola M., Furia A., Palmieri M. Repression of the IL-6 gene is associated with hypermethylation. Biochem. Biophys. Res. Commun. 1999, 258:644-647.
2. Armenante F., Merola M., Furia A., Tovey M., Palmieri M. Interleukin-6 repression is associated with a distinctive chromatin structure of the gene. Nucleic Acids Res. 1999, 27:4483-4490.
3. Bird A. Putting the DNA back into DNA methylation. Nat. Genet. 2011, 43:1050-1051.
4. Chalaris A., Garbers C., Rabe B., Rose-John S., Scheller J. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer. Eur. J. Cell Biol. 2011, 90:484-494.
5. Chen J., Ivashkiv L.B. IFN-gamma abrogates endotoxin tolerance by facilitating toll-like receptor-induced chromatin remodeling. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:19438-19443.
6. Dandrea M., Donadelli M., Costanzo C., Scarpa A., Palmieri M. MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines. Nucleic Acids Res. 2009, 37:6681-6690.
7. Faggioli L., Costanzo C., Donadelli M., Palmieri M. Activation of the interleukin-6 promoter by a dominant negative mutant of c-Jun. Biochim. Biophys. Acta Molec. Cell Res. 2004, 1692:17-24.
8. Faneyte I.F., Kristel P.M.P., van de Vijver M.J. Determining MDR1/P-glycoprotein expression in breast cancer. Int. J. Cancer 2001, 93:114-122.
9. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998, 102:1369-1376.
10. Garbers C., Thaiss W., Waetzig G.H., Jones G.W., Floss D.M., Lorenzen I., Grotzinger J., Jones S.A., Rose-John S., Scheller J. Inhibition of Interleukin 6 classic signaling is a novel function of soluble gp130 which is controlled by the ratio of Interleukin 6 and soluble Interleukin 6 receptor. Cytokine 2011, 56:60-61.
11. Gerlo S., Haegeman G., Vanden Berghe W. Transcriptional regulation of autocrine IL-6 expression in multiple myeloma cells. Cell Signal. 2008, 20:1489-1496.
12. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 2003, 374:1-20.
13. Kishimoto T. IL-6: from its discovery to clinical applications. Int. Immunol. 2010, 22:347-352.
14. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
15. Kreuter A., Hyun J., Skrygan M., Sommer A., Bastian A., Altmeyer P., Gambichler T. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma. Br. J. Dermatol. 2006, 155:600-607.
16. Lee J.Y., Kim N.A., Sanford A., Sullivan K.E. Histone acetylation and chromatin conformation are regulated separately at the TNF-alpha promoter in monocytes and macrophages. J. Leukoc. Biol. 2003, 73:862-871.
17. Liang M.D., Zhang Y., McDevit D., Marecki S., Nikolajczyk B.S. The interleukin-1 beta gene is transcribed from a poised promoter architecture in monocytes. J. Biol. Chem. 2006, 281:9227-9237.
18. Ndlovu M.N., Van Lint C., Van Wesemael K., Callebert P., Chalbos D., Haegeman G., Vanden Berghe W. Hyperactivated NF-kappa B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the Interleukin-6 gene promoter in metastatic breast cancer cells. Mol. Cell. Biol. 2009, 29:5488-5504.
19. Nikolajczyk B. Regulation of cytokine transcription in the context of chromatin. Arch. Immunol. Ther. Exp. 2006, 54:299-305.
20. Nile C.J., Read R.C., Akil M., Duff G.W., Wilson A.G. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum. 2008, 58:2686-2693.
21. Ramirez-Carrozzi V.R., Nazarian A.A., Li C.C., Gore S.L., Sridharan R., Imbalzano A.N., Smale S.T. Selective and antagonistic functions of SWI/SNF and Mi-2 beta nucleosome remodeling complexes during an inflammatory response. Genes Dev. 2006, 20:282-296.
22. Razin A. CpG methylation, chromatin structure and gene silencing - a three-way connection. Embo J. 1998, 17:4905-4908.
23. Samuel J.M., Kelberman D., Smith A.J., Humphries S.E., Woo P. Identification of a novel regulatory region in the interleukin-6 gene promoter. Cytokine 2008, 42:256-264.
24. Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta Molec Cell Res. 2011, 1813:878-888.
25. Schroeder A.K., der Ohe M.D., Kolling U., Altstaedt J., Uciechowski P., Fleischer D., Dalhoff K., Ju X.S., Zenke M., Heussen N., Rink L. Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 receptor antagonist and chemokines, but fail to produce pro-inflammatory mediators. Immunology 2006, 119:317-327.
26. Spooren A., Kooijman R., Lintermans B., Van Craenenbroeck K., Vermeulen L., Haegeman G., Gerlo S. Cooperation of NF kappa B and CREB to induce synergistic IL-6 expression in astrocytes. Cell. Signal. 2010, 22:871-881.
27. Vanden Berghe W., De Bosscher K., Boone E., Plaisance S., Haegeman G. The nuclear factor-kappa B engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J. Biol. Chem. 1999, 274:32091-32098.
28. Wessels I., Fleischer D., Rink L., Uciechowski P. Changes in chromatin structure and methylation of the human interleukin-1 beta gene during monopoiesis. Immunology 2010, 130:410-417.
29. Wessels I., Rosenkranz E., Ventura Ferreira M., Neuss S., Zenke M., Rink L., Uciechowski P. Activation of IL-1β and TNF-α genes is mediated by the establishment of permissive chromatin structures during monopoiesis. Immunobiology 2013, 12:521-529.